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Deletion of the Major Bullous Pemphigoid Epitope
Region of Collagen XVII Induces Blistering,
Autoimmunization, and Itching in Mice
Tiina Hurskainen1,2,8, Nina Kokkonen1,2,8, Raija Sormunen3,4, Joanna Jackow5, Stefanie Lo¨ffek6,
Raija Soininen3,7, Claus-Werner Franzke6, Leena Bruckner-Tuderman6 and Kaisa Tasanen1,2
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering skin disease with a
characteristic of pruritus and blistering. BP patients carry inflammation-triggering autoantibodies against the
collagen XVII (ColXVII, also known as BP180) juxtamembraneous extracellular noncollagenous 16A (NC16A)
domain involved in ectodomain shedding. Deletion of the corresponding NC14A region in a genetically modified
mouse model (DNC14A) decreased the amount of ColXVII in skin, but it did not prevent ectodomain shedding.
Newborn DNC14A mice had no macroscopic phenotypic changes. However, subepidermal microblisters,
rudimentary hemidesmosomes, and loose basement membrane zone were observed by microscopy. DNC14A
mice grow normally, but at around 3 months of age they start to scratch themselves and develop crusted
erosions. Furthermore, perilesional eosinophilic infiltrations in the skin, eosinophilia, and elevated serum IgE
levels are detected. Despite the removal of the major BP epitope region, DNC14A mice developed IgG and IgA
autoantibodies with subepidermal reactivity, indicating autoimmunization against a dermo-epidermal junction
component. Moreover, IgG autoantibodies recognized a 180-kDa keratinocyte protein, which was sensitive to
collagenase digestion. We show here that DNC14A mice provide a highly reproducible BP-related mouse model
with spontaneous breakage of self-tolerance and development of autoantibodies.
Journal of Investigative Dermatology (2015) 135, 1303–1310; doi:10.1038/jid.2014.443; published online 6 November 2014
INTRODUCTION
Chronic pruritus is a major symptom in numerous dermatolo-
gical diseases (Metz and Sta¨nder, 2010; Garibyan et al., 2013).
In the most common autoimmune subepidermal blistering
skin disease, bullous pemphigoid (BP), patients suffer from
pruritus for weeks to months, sometimes even years, before
development of other symptoms (Di Zenzo et al., 2012;
Schmidt and Zillikens, 2013; Nishie, 2014; Schmidt et al.,
2014). BP is characterized by the presence of autoantibodies
against structural components of hemidesmosomes, with
transmembrane collagen XVII (ColXVII, also known as
BP180) being the main target. Nearly all BP patients have
autoantibodies against the extracellular noncollagenous 16A
(NC16A) domain of ColXVII (Giudice et al., 1993; Schmidt
and Zillikens, 2013; Nishie, 2014). In addition to harboring
multiple epitopes to BP autoantibodies, the NC16A domain
has a fundamental role in ColXVII trimerization (Franzke et al.,
2003; Van den Bergh and Giudice, 2003; Franzke et al.,
2005). The NC16A domain is also the main cleavage area for
shedding proteases that constitutively release a soluble
ectodomain of ColXVII from the cell surfaces (Franzke et al.,
2009; Nishie et al., 2010).
In BP, autoantibodies trigger an inflammation process
resulting in the destruction of hemidesmosomes and dermal–
epidermal separation (Ujiie et al., 2010b; Di Zenzo et al.,
2012). Clinically, BP presents typically with tense blisters and
erythema, frequently in conjunction with urticarial plaques
(Schmidt and Zillikens, 2013). The most important diagnostic
method for BP is the direct immunofluorescence (IF) staining
of perilesional skin biopsy showing subepidermal linear IgG
and/or complement (C)3 staining at the dermo–epidermal
junction (DEJ) (Di Zenzo et al., 2012; Schmidt and Zillikens,
2013). In addition, IgE-class autoantibodies and elevated
serum IgE levels are observed in a subgroup of BP patients
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(Fania et al., 2012). Histological examination of lesional skin
reveals subepidermal blisters with inflammatory infiltration
of eosinophils and lymphocytes in the upper dermis
(Di Zenzo et al., 2012; Schmidt and Zillikens, 2013; Nishie,
2014).
Previously developed animal models on BP rely on passive
transfer of autoantibodies or recombinant peptides to neonatal
(Liu et al., 1993; Nishie et al., 2007; Liu et al., 2008) and adult
mice (Hirose et al., 2011; Oswald et al., 2012). Injection of
autoantibodies or repeated immunization induces skin blister-
ing and deposition of IgG and C3 on the DEJ. In the active
mouse model for BP, ColXVII humanized mice produce con-
tinuously anti-human ColXVII antibodies and develop blisters
and erosions on their skin in addition to typical immuno-
pathological features of BP (Ujiie et al., 2010a). None of the
previous mouse models are reported to have itching.
To better understand the multiple functions of the human
NC16A domain of ColXVII, we have generated a genetically
modified mouse line carrying a deletion in the corresponding
NC14A region of murine ColXVII (DNC14A mice). Newborn
and adult DNC14A mice have no obvious phenotypic changes
distinct from the wild-type (WT) ones until the age of 2–3
months when they develop itch and begin to scratch. We
show here that DNC14A mice have subepidermal microblis-
ters and immunopathological findings similar to BP patient
samples. Thus, the phenotype of DNC14A mice has features of
both inherited (spontaneous blisters) and acquired (pruritus,
blistering, and development of autoantibodies) bullous skin
disease.
RESULTS
Generation of DNC14A mice
To generate the DNC14A mouse line with a deletion of exon
18, Col17a1 knockout mice (Hurskainen et al., 2012) were
bred with a Cre recombinase–carrying mouse strain
(Figure 1a). The deletion of exon 18 of Col17a1 gene led to
the depletion of 72 amino acids (aa) in the NC14A domain (aa
498–569 out of 498–573; Li et al., 1993), which was detected
in immunoblotting of the skin extracts as a decrease of about
10 kDa in molecular weight and loss of signal with the
domain–specific antibody (Figure 1b). Interestingly, despite
the deletion of the region containing physiological cleavage
sites (aa 514–526 in human; Nishie et al., 2010), shed
ectodomain was detected in the skin extracts of DNC14A
mice (EC-7 in Figure 1b).
ColXVII protein levels in skin extracts were quantified by
immunoblotting and densitometric analysis. DNC14A mouse
skin contains on average about half the amount of ColXVII
found in WT mice, with large variation between individuals
(Figure 1c). In quantitative real-time PCR analysis of ColXVII
mRNA levels, no differences between DNC14A and WT
mouse skin (mean 0.93-fold vs. 1.0) were observed, nor were
any major differences detected in the expression levels of
proteins that interact with ColXVII, e.g., integrin b4, laminin
g2, and keratins 5, 10, and 14 (data not shown).
DNC14A mice have subepidermal blisters and develop itching
Newborn DNC14A mice have no obvious phenotype distinct
from WT. Male and female DNC14A pups are born in equal
ratios. They grow normally but begin to scratch later
(Figure 2a and b; Supplementary Movie S1 online), typically
(43%) at the age of 10–16 weeks (Figure 2e). The scratching is
very intense (Supplementary Movie S1 online). Among male
mice, 31 (62%) out of 50 mice that were allowed to age up to
1 year began to scratch themselves, whereas 43 (83%) out of
52 female mice were scratching. Only 19% of DNC14A mice
reached the age of 1 year without scratching. However, a few
developed itching later. Simultaneously with scratching,
DNC14A mice develop large erosions (Figure 2b–d) that are
mostly covered by crusts on the nape of the neck, ears, snout,
and tail. In some cases, erosions were also found on paws
(Figure 2d). In addition, DNC14A mice appear to gray early,
their fur is thinner than that of their WT littermates (Figure
2a–d), and some mice carry patchy fur or even total hair loss.
Histopathological analysis revealed subepidermal micro-
blisters in the skin of newborn DNC14A mice (Figure 3b),
whereas none were detected in newborn WT skin (Figure 3a).
In the perilesional skin of scratching mice, vacuolization in the
DEJ, hyperkeratosis, thickening of the epidermis, and hyper-
proliferation of fibroblasts were observed (Figure 3c and d).
17 18 19 20
17 lox
P
lo
xP
lo
xP
17
19
PGK neoR
Cre recombinase
19
20
20
+/+ +/––/–
2122
2122 kDa
180
180
130
130
35
EC-7
W
T
NC14A
ΔN
C1
4A
GAPDH WT
n =12
3
2
1.5
1
0.5
0
Co
IX
VI
I f
ol
d 
ch
an
ge 2.5
ΔNC14A
n =18
2122
2,831 bp
ΔNC14A allele
Knockout allele
WT allele
Col17a1
2,615 bp
Figure 1. Generation and characterization of DNC14A mice. (a) Cre recombination removes the loxP-flanked PGK-neoR cassette, and the reading frame is
restored in the targeted Col17a1 locus lacking the 216-bp exon 18. Exons are marked as rectangles and primers with arrows. Bottom: genomic DNA PCR products.
(b) Immunoblotting of skin extracts of adult mice. The domain–specific antibody NC14A revealed the absence of the NC14A domain. EC-7 binds to the
extracellular domain and shows lower molecular weight of ColXVII in the DNC14A mouse sample. A shed ectodomain, approximately 110–120 kDa, was
detected in both WT and DNC14A skin. GAPDH was used as a loading control. (c) Relative ColXVII protein levels quantified from immunoblots showed variation
between individuals. Bars, mean values. ColXVII, collagen XVII; NC, noncollagenous; WT, wild type.
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Figure 2. Appearance of the DNC14A mice. (a) The fur of DNC14A mice appears to turn gray, and it is thinner than the fur of the WT mice at the same age (13
weeks). (b–d) Because of scratching, DNC14A mice develop large erosions and crusts in their skin. Symptomatic skin is also seen on the ears (c) and paws (d) of
DNC14A mice (b¼13, c¼20, d¼ 9 weeks). (e) The number of mice in time point (age in weeks) when scratching was initiated. The age when mice were
observed to start scratching was typically 10–16 weeks (n¼39). In total, 82 DNC14A mice out of 102 were detected to scratch at varying age, a few (n¼ 8) not
until 452 weeks old. NC, noncollagenous; WT, wild type.
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Figure 3. Histopathological and ultrastructural analysis of skin. (a–f) Hematoxylin–eosin-stained skin sections. (a) Newborn WT skin. (b) Subepidermal
microblisters (white arrow) in the skin of the newborn DNC14A mouse. (c–f) Thickening of the epidermis, subepidermal blistering (white arrows), hyperkeratosis,
and eosinophils (black arrows), as well as hyperproliferation of fibroblasts (asterisk), were detected in the perilesional skin of scratching DNC14A mice. Scale
bars¼ 50mm. (g, h) Transmission electron microscopy of adult WT (g) and DNC14A (h) mouse skin. (h) Malformed hemidesmosomes (white arrows) and basement
membrane zone (arrowheads) in the skin of adult DNC14A mouse. (i, j) Immunoelectron microscopy with ectodomain-specific antibody (EC-7) showed ColXVII
localization (black arrows) in hemidesmosomes and at the dermo-epidermal junction in WT (i) and DNC14A (j) skin. Scale bars¼ 500 nm. ColXVII, collagen XVII;
ECM, extracellular matrix; NC, noncollagenous; WT, wild type.
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Healthy skin of adult DNC14A mice, remote from the
scratching areas, e.g., abdominal skin, did not differ from
WT skin (data not shown).
Ultrastructural analysis of the healthy skin from newborn
and adult DNC14A mice revealed several changes in the DEJ.
DNC14A mice had rudimentary and malformed hemidesmo-
somes (Figure 3h). The number of hemidesmosomes also
appeared to be lower than that in WT skin (Figure 3g and
h). The basement membrane of DNC14A mice was loosened,
and the space between the basement membrane and the basal
keratinocytes was wider than in WT skin (Figure 3g and h). In
addition, anchoring fibrils in DNC14A skin were short,
unorganized, and, in some cases, abnormally clustered
(Figure 3h).
Immunoelectron microscopic analysis with ectodomain-
specific antibody showed localization of ColXVII in hemi-
desmosomes and basement membrane zone in both WT and
DNC14A mouse skin (Figure 3i and j). Similarly to immuno-
blotting findings, more labeling was detected in WT skin
relative to DNC14A mouse skin, supporting the difference in
the total amount of ColXVII protein.
Inflammatory factors in blood and skin of DNC14A mice with
itch
Infiltration of eosinophils and mast cells was seen in perile-
sional and lesional skin samples of DNC14A mice (Figure 3e
and f). However, no statistically significant changes in the
number of mast cells or their degranulation were observed in
the DNC14A mouse skin compared with the WT samples (data
not shown). Total blood cell count revealed increased number
of monocytes, neutrophils, eosinophils, and basophils in the
circulation of DNC14A mice (Supplementary Table S1 online).
IgG, IgG1, and IgE protein levels were markedly increased
in the healthy skin of itching DNC14A mice, but variation
between individuals was high (Figure 4a–c). DNC14A mice
without itch had IgG, IgG1, and IgE levels comparable to the
WT mice.
Direct IF with anti-IgG and anti-IgG1 showed linear deposi-
tion in the DEJ of healthy skin of scratching DNC14A mice
(IgG 11/14, IgG1 9/11 positive; Figure 5b and c), which
was not detected in either WT (Figure 5a) or newborn
DNC14A mouse skin (data not shown). Direct IF also revealed
linear IgA deposition in the DEJ of the DNC14A mouse skin
(Figure 5d), whereas IgE deposition was not detected (data
not shown). Fragmented ColXVII-specific staining in DNC14A
skin (Figure 5b–d) further supports immunoblotting results
(Figure 1c) of decreased amounts of ColXVII.
To analyze circulating autoantibodies, sera from scratching
DNC14A mice were collected at the time of euthanasia (see
Figure 2e). Indirect IF of frozen skin sections with sera and
anti-IgG resulted in staining of the DEJ in the WT skin in 9 out
of 13 tested cases (Figure 5e). The serum-specific staining
colocalized with ColXVII-specific staining. Both the DNC14A
mouse sera and ColXVII antibodies reacted to the epidermal
side of salt-split WT mouse skin (Figure 5f). IgG deposition
was not detected in direct or indirect IF with nonscratching
DNC14A samples (data not shown). Moreover, serum IgE
content analyzed by ELISA revealed significantly increased
total IgE levels in the samples of DNC14A mice (Figure 4d).
Neither IgE deposits nor serum-specific IgE labeling was
detected in direct or indirect IF (data not shown).
Finally, scratching mouse sera were used to detect antigens
in WT keratinocyte extract by immunoblotting (Figure 6a).
Anti-IgG as a secondary antibody revealed a protein with a
molecular weight of about 180 kDa that was eliminated with
collagenase treatment. ColXVII-specific antibody gave a simi-
lar result, whereas WT (Figure 6a) and nonscratching DNC14A
sera (data not shown) did not react with the 180-kDa protein.
Scratching mice sera and anti-IgG bound also to the 180-kDa
protein immunoprecipitated with ColXVII-specific antibody
from WT mouse keratinocytes (Figure 6b).
DISCUSSION
Besides acting as the major pathogenic epitope for BP, the
NC16A domain has a fundamental role in ColXVII trimeriza-
tion and ectodomain shedding (Franzke et al., 2009; Nishie
et al., 2010). Here, we have created a genetically modified
mouse model with a deletion in the corresponding NC14A
domain and demonstrate that, despite this modification, the
ectodomain of ColXVII is shed in vivo and ColXVII is localized
correctly to the cell surface. The most interesting finding in
this study is that the majority of DNC14A mice begin to
scratch themselves at the age of 10–16 weeks. Scratching
is considered a consequence of itching, as it localizes to the
same areas as scratching owing to histamine injection
(Shimada and LaMotte, 2008). Even though pruritus is a
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Figure 4. Increased immunoglobulin levels in DNC14A mice. (a, b) Skin
extracts of WT and DNC14A mice were analyzed by immunoblotting with
anti-IgG, anti-IgG1, and anti-IgE-specific antibodies. GAPDH was used as a
loading control. (c) Quantified immunoglobulin levels in skin compared with
one WT sample and reported as fold-change values. (d) Total IgE concentration
in serum samples analyzed by ELISA. NC, noncollagenous; WT, wild type.
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prominent symptom of BP, to the best of our knowledge, none
of the previous experimental BP models have itch as a
manifestation (Leighty et al., 2007; Ujiie et al., 2010b;
Nishie, 2014). Simultaneously with itching and scratching,
erosions and crusts developed in the skin of DNC14A mice.
Blistering was not observed, although subepidermal micro-
blistering was detected in skin histology. Similar crusted
erosions without visible blisters, as well as thickening of the
epidermis, hyperkeratosis, and accumulation of eosinophils in
skin biopsies, have previously been described in a BP model
with repetitive peptide immunization of immunocompetent
adult mice (Hirose et al., 2011). On the other hand, blistering
or epidermal detachment by gentle friction has been detected
in BP models with passive transfer of autoantibodies or
immune cells (Liu et al., 1993; Nishie et al., 2007; Ujiie
et al., 2010a; Chiriac et al., 2013). Skin symptoms of DNC14A
mice are localized in the same areas as in preimmunized mice
with passive transfer of ColXVII-specific antibodies, where the
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with ColXVII in WT untreated (e) and salt-split (f) skin, both signals on epidermal side of the blister (asterisk). Arrowheads, basement membrane zone.
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Figure 6. Antigen detection with scratching DNC14A mouse sera. (a) WT and
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antibodies in immunoblotting to detect the autoantigen in WT mouse
keratinocytes. Anti-mouse IgG was used as a secondary antibody. A 180-kDa
protein was detected with scratching mouse serum and ColXVII-specific
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in collagenase-treated cell extract. (b) ColXVII-specific antibody (EC-7) was
used in the immunoprecipitation of WT keratinocyte extract. The
immunoprecipitated 180-kDa protein was detected with scratching DNC14A
mouse serum (age 62 weeks) and anti-IgG but not with WT serum. ColXVII,
collagen XVII; NC, noncollagenous; WT, wild type.
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first signs of blistering appeared 3–5 days after immunization
and required about 10 days to develop to a full-blown
blistering disease (Oswald et al., 2012). Owing to ethical
reasons, DNC14A mice are euthanized when severe scratch-
ing is initiated; it is therefore not known whether clear blisters
would develop later.
In mice, humoral immunity requires several weeks to
mature after birth (Adkins et al., 2004), which supports the
assumption that humoral immune response would cause
pruritus in the DNC14A mice. In addition, the lag period
preceding the symptoms after birth indicates that it is not the
maternal antibodies but rather the individual’s own immune
response that is responsible for the development of itch. The
presence of IgG and IgA autoantibodies with subepidermal
reactivity in the DNC14A scratching mice resembles closely
the staining seen by direct and indirect IF of BP patients. In
addition, binding of serum IgG antibodies to the 180-kDa
keratinocyte protein that was sensitive to collagenase diges-
tion, as well as to the ColXVII-immunoprecipitated protein,
strongly suggests that ColXVII could be the target of the
autoantibodies. It is known that the physiological shedding
of ColXVII generates neoepitopes that could serve as a target
of BP autoantibodies (Nishie et al., 2010). Furthermore, in
linear IgA dermatosis, IgA antibodies target the shed
ectodomain more efficiently than the full-length ColXVII
(Schumann et al., 2000). The reasons why genetically modi-
fied ColXVII present in the DNC14A mice causes the breaking
of self-tolerance remains largely elusive. At the moment, it
is not known whether the generation of autoantibodies is
provoked by the continuous expression of aberrantly
processed ColXVII ectodomain, possible conformational
changes in the triple helical structure of ColXVII, malformed
hemidesmosomes, or other still unidentified triggers.
In BP, the binding of autoantibodies to ColXVII leads to the
activation of complement and inflammatory pathways, but
a complement-independent pathway, as well as pathways
including IgE autoantibodies, are also suggested to be involved
(Nishie, 2014). In a humanized BP mouse model, passive
transfer of IgG1 causes subepidermal blisters and deposition of
IgG1, C1q, and C3, in addition to infiltration of neutrophils
and mast cell degranulation in the skin (Li et al., 2010).
Eosinophilic infiltration and eosinophilia are commonly
observed in the majority of BP patients, but they are rarely
found in BP mouse models (Hirose et al., 2011; Nishie, 2014).
The skin of scratching DNC14A mice contained linear
deposition of IgG, whereas C3 deposition was not detected
(data not shown). Although in BP patients direct IF analysis
quite often shows simultaneous accumulation of IgG and C3
(Schmidt and Zillikens, 2013; Nishie, 2014), time-course
studies with repetitive immunizations have indicated that
deposition of C3 in mouse skin occurs only after IgG
deposition is decreased within 6 weeks (Hirose et al., 2011).
Serum IgE autoantibodies are assumed to be an early
pathogenic event of BP and to retract especially eosinophils
into skin lesions (Ishiura et al., 2008; Fania et al., 2012).
Similar to a majority of BP patients (Fania et al., 2012; Nishie,
2014), total IgE levels in sera and skin of scratching DNC14A
mice were highly increased, but tissue-bound or circulating
antigen-specific IgE was not detected (data not shown). In
addition, both eosinophils in perilesional skin and eosino-
philia were detected, suggesting that IgE and eosinophils may
be involved in the pruritus of DNC14A mice.
Besides pruritus and the development of autoantibodies,
DNC14A mice have some features of inherited blistering skin
disease associated with ColXVII mutations, i.e., junctional
epidermolysis bullosa. Junctional epidermolysis bullosa
patients carrying COL17A1 mutations develop generalized
or localized blisters and have hair, nail, and enamel defects
(Kiritsi et al., 2011; Fine et al., 2014). To date, NC16A domain
deletions have not been reported in humans (Kiritsi et al.,
2011). DNC14A mice do not develop large blisters, but
microblisters are detected already in newborn skin.
Junctional epidermolysis bullosa patients are also reported to
have varying degrees of alopecia (Kiritsi et al., 2011).
DNC14A mice appear to have thinner fur than their WT
littermates, and some develop patchy to total hair loss. Auto-
antibodies have not been reported in junctional epidermolysis
bullosa, but some patients with recessive dystrophic EB
generate circulating autoantibodies against mutated collagen
VII (Tampoia et al., 2013; Woodley et al., 2014). Contrary
to DNC14A mice, these autoantibodies do not bind to the
patients’ skin.
DNC14A mice are a BP-related mouse model in which the
primary symptom is pruritus, as in the majority of human BP
patients. Differing from some previous models (Nishie et al.,
2007; Liu et al., 2008; Nishie et al., 2010; Hirose et al., 2011;
Chiriac et al., 2013), DNC14A mice are immunocompetent
and mature, which enables long-term monitoring of natural
immune responses. In addition, no injection of substances or
other stress-causing experimental procedures are required,
because symptoms develop spontaneously. Thus, DNC14A
mice provide an excellent model to study the breakdown of
self-tolerance, as well as the early stages and development of
autoimmune blistering skin disease. Itching, subepidermal
blistering, eosinophilia, eosinophilic infiltrations, and eleva-
ted IgE levels closely resemble the key features of BP patients.
The presence of IgG and IgA autoantibodies with sub-
epidermal reactivity and, especially, recognition of a 180-
kDa collagenase-sensitive polypeptide suggest strongly that
autoantibodies are ColXVII-specific. In our opinion, DNC14A
mice represent a promising candidate among the existing
BP mouse models.
MATERIALS AND METHODS
Generation and characterization of DNC14A transgenic mice
Generation of Col17a1 knockout mice in C57BL/6 background was
described in (Hurskainen et al., 2012). Exon 18 and the surrounding
intron sequences of the Col17a1 gene were replaced by the PGK-neo
cassette flanked by loxP sequences (PGK-neoR). Breeding with mice
carrying the Cre recombinase gene (Sakai and Miyazaki, 1997) led to
removal of the PGK-neoR cassette and restored the reading
frame. This resulted in a viable ColXVII mutant mouse strain with a
deletion in the NC14A region. The project has been approved by
the University of Oulu Animal Ethics Committee and the Southern
Finland Regional State Administrative Agency (license number ESAVI/
5255/04.10.03/2011). The animal care principles and experimental
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procedures are in accordance with national Finnish legislation, the
European Convention for the protection of vertebrate animals
used for experimental and other scientific purposes (ETS 123),
and EU Directive 2010/63/EU. All efforts were made to mini-
mize the suffering of experimental animals. The humane end
point defined in the license for DNC14A mice is the initiation of
scratching.
Genomic DNA was isolated from ear samples by routine methods
and analyzed by PCR using Col17a1 exon 17– and 22–specific
primers (sense 50-TGCGGCTCCTGCTGCAGCTGG-30, antisense
50-CTTTGGTCCTTCCGGGCCAGG-30). The amplified PCR products
were analyzed by agarose gel electrophoresis.
Isolation and cultivation of primary keratinocytes
Primary keratinocytes were isolated from newborn WT mice, as
described in (Lo¨ffek et al., 2014). Primary keratinocytes were
immortalized by infecting with pseudotyped retroviruses carrying
the HPV16 E6 and E7 genes. Retroviral particles were generated by
co-transfecting Phoenix gag-pol cells with pLSXN16E6E7 (a generous
gift from Dr Denise Galloway, Fred Hutchinson Cancer Research
Center, Seattle, WA) and pVSV-G plasmids with Lipofectamine 2000
(Life Technologies, Grand Island, NY). Keratinocytes were infected
with concentrated culture medium containing viral particles
and 2mg ml 1 polybrene for 24 hours. Thereafter, virus-containing
medium was replaced by CnT-07 medium (CELLnTEC, Bern,
Switzerland).
Immunoblotting analysis of mouse skin extracts and
keratinocytes
Snap-frozen abdominal skin biopsies collected from euthanized mice
were homogenized in RIPA buffer (50 mM Tris, pH 7.5, 150 mM NaCl,
0.5% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, Protease
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO), 2 mM EDTA) and
clarified by centrifugation. Ethanol-precipitated proteins were ana-
lyzed by immunoblotting with ColXVII domain–specific antibodies
EC-7 (aa 1030–1134; Oswald et al., 2012) and NC14A (aa 479–573;
Franzke et al., 2002). GAPDH (Santa Cruz Biotechnologies, Santa
Cruz, CA) was used as a loading control, and horseradish peroxidase
(HRP)–conjugated anti-rabbit IgG (Sigma-Aldrich) as a secondary
antibody. HRP-conjugated anti-mouse IgG (Abliance, Compiegne,
France), anti-mouse IgG1 (Life Technologies) and anti-mouse IgE
(Bethyl Laboratories, Montgomery, TX) were used for quantification of
immunoglobulins in skin extracts. Proteins were visualized with
enhanced chemiluminescence substrates (ECL Prime, GE Healthcare,
Buckinghamshire, UK) and LAS-3000 Image analyzer system (Fujifilm,
Tokyo, Japan). Specific protein bands were quantified using the ImageJ
software (NIH, Bethesda, MA) and normalized against GAPDH.
Immortalized keratinocytes were grown for 48 hours in CnT-07
medium containing 50mg ml 1 ascorbic acid. Cells were lysed in
RIPA buffer, as described above. Aliquots of cell extracts were treated
with 40 U ml 1 highly purified bacterial collagenase (type III, Sigma-
Aldrich) for 2 hours at þ 37 1C. ColXVII was immunoprecipitated
from keratinocyte cell extract by using EC-7 antibody and Protein-A-
Sepharose (GE Healthcare) overnight at þ 4 1C. Immunoprecipitated
proteins were eluted in SDS-sample buffer. Sera (1:1000) collected
from WT and DNC14A mice and HRP-conjugated anti-mouse
IgG (Abliance) were used to detect the keratinocyte antigens by
immunoblotting.
Morphologic analysis of the mouse skin
Skin biopsies were fixed in 10% buffered formalin and paraffin-
embedded. Five-micrometer sections were stained with hematoxylin–
eosin for histologic analysis by light microscopy (Leica DM3000,
Wetzlar, Germany).
Indirect and direct IF analyses were performed in 5-mm frozen,
nonfixed sections. Murine WT and DNC14A sera (1:50) and poly-
clonal antibody EC-7 (1:500) were used as primary antibodies, and
Alexa Fluor 488–conjugated anti-mouse IgG or Alexa Fluor 594–
conjugated anti-rabbit IgG (Life Technologies) were used as second-
ary antibodies. ImmuMount (ThermoScientific, Middletown, VA)-
embedded sections were photographed with Olympus FluoView
FV1000 confocal microscope using  100 oil-immersion objective
and appropriate filter settings. Direct IF with Alexa Fluor 488–
conjugated anti-mouse IgG and IgG1 and FITC-conjugated anti-
mouse IgA antibodies (Life Technologies) was performed similarly
to indirect IF but without sera.
To prepare salt-split skin samples, WT mouse skin biopsies were
treated with 1 M NaCl for 48 hours at 4 1C. Epithelia were separated
from the dermis with forceps, and biopsies were frozen.
For transmission and immunoelectron microscopy, specimens from
mouse skin samples were processed and analyzed as previously
described (Hurskainen et al., 2012), except that skin cryosections
were exposed to polyclonal EC-7 (1:100) antibody.
Blood analysis
Blood cell count was analyzed using a flow cytometer at NordLab
Oulu, Finland. Blood samples were collected from terminally
anesthetized mice by orbital bleeding in K-EDTA Microvette tubes
(Sarstedt, Nu¨mbrecht, Germany), and serum was separated by
centrifugation and stored at  70 1C. Total IgE concentration in
mouse sera was measured using the Mouse IgE ELISA MAX Deluxe
Set (BioLegend, San Diego, CA) according to the manufacturer’s
instructions.
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